Local Time
English (UK) Deutsch (DE) Français (FR) Español (ES) Italian (IT)
The DEA is not on Your Side
Author: Sarah  25/11/2017 - 23:33:00

This week, the Drug Enforcement Administration (DEA) approved the synthetic cannabis drug Syndros for Schedule II. Cannabis on the other hand, will remain a Schedule I drug, under the same classification as heroin: extremely dangerous and with no accepted medical value. The DEA gave their reasoning in this report. Basically, because the synthetic cannabinoid delta-9-tetrahydrocannabinol aka delta-9-THC was developed specifically for medical use, it has accepted medical value. What the DEA is saying here is that the fake cannabis developed in a lab by a pharmaceutical company, it is safer than cannabis. 

First off, this is a Bad Argument

This is a bad argument in many ways. First of all, heroin was developed for medicinal use by the Bayer corporation, one of the biggest pharmaceutical companies in the world. Now heroin is widely regarded as the most dangerous drug, responsible for the deaths of thousands of people per year. So the DEA’s argument is already debunked.

Secondly, it makes no sense to argue that something synthetic is better than the real thing. This is why synthetics are created to be as close to the original as possible. If they weren’t, then what would be the point of a synthetic in the first place.

Lastly, when have you ever heard anyone express a preference for the fake version of something. Does anyone prefer fake wood paneling over real wood? Does anyone think that orange soda is better for you than an orange? I guess some people prefer fake boobs over real ones, but this is the only example I can think of. If you think of anymore situations where people prefer fake over real, please let me know in the comments.

DEA Responses to Public Comments Show This

The DEA’s responses to comments they received from the public shows that they know that their argument is bullshit, and they don’t really seem to care. When a couple of people commented on their concern that a pharmaceutical company would be profiting off of the sale of synthetic cannabis while cannabis itself remained illegal. Their response was as follows:

The DEA notes that FDA-approved products of oral solutions containing dronabinol have an approved medical use, whereas marijuana does not have an approved medical use and therefore remains in schedule I. Regarding the comments related to pharmaceutical companies and the approval of FDA drugs, these comments are outside the scope of this rulemaking because they do not relate to the factors determinative of control of a substance [21 U.S.C. 811(c)] or the criteria for placement of a substance in a particular schedule [21 U.S.C. 812(b)].

Basically, because Syndros was developed for medical use, it’s safer and has a real medical value, whereas  cannabis is not and is therefore illegal. It should be noted here that Insys, the company behind Syndros, has a pretty dirty history. Insys is responsible for creating Fentanyl, an extremely dangerous and addictive opioid. Several people in the company have been arrested for bribery and corruption charges, including the billionaire founder of Insys, John Kapoor. The company is also being sued by several states  for its role in the opiate crisis. Insys also spent half a million dollars to defeat the legalization effort in Arizona.

The fact that the DEA would trust a corporation responsible for the opiate crisis shows which side they’re on. It’s not yours.

Featured Image Source: soberinfo.com

Do you think the DEA is on your side? Tell us in the comments!

The post The DEA is not on Your Side appeared first on I Love Growing Marijuana.

Original article from ilovegrowingmarijuana.com:The DEA is not on Your Side


©2018 - Hempyreum.org - News aggregator about Hemp and Cannabis [Beta] | All rights and ownership of the contents belong to their respective holders